Research article · 2018
Research articlePublished 2016
Evaluation of DNA Methylation of MAP9 Gene in Breast Cancer as Epigenetic Biomarker
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Recent findings indicate epigenetic modifications as key factors in breast carcinogenesis. The abnormal methylation patterns of genes are among the consequences of epigenetic changes. The DNA methylation is involved in the regulation of gene activity and abnormal DNA methylation is associated with various diseases, including cancer. Due to the importance of epigenetics in cancer, particularly breast cancer, it seems to perform the most effective methods of prediction, detection and tracking of recurrence, and the availability of suitable biomarkers. In this study, the MAP9 (Microtubule-Associated Protein 9) gene methylation was examined as an epigenetic biomarker of cancer. Methods: We evaluated 30 breast cancer samples and 30 normal samples to identify diagnosis biomarkers for breast cancer. Sample of breast cancers were identified, with different Clinical and pathological data, which might be related with changes in MAP9 gene methylation. DNA was extracted from whole blood of breast cancer patients and healthy samples. The methylation-sensitive restriction enzymes were used to identify methylated site in epigenetic marker. Methylation-sensitive enzyme cannot cut hypermethylated sequences. Methylation-sensitive enzyme is not capable of cutting sequences of MAP9 gene, thus replication occurs. Results: MAP9 gene is significantly hypermethylated in breast cancer (P 0.05). Conclusion: In this study indicated MAP9 gene methylation changes in breast cancer and it can be used as molecular biomarker for breast cancer diagnosis.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 21 Jun 2017
Breast cancer prediction and early detection: The potential of cytomorphology and hTERT gene DNA methylation
Conference abstract · 25 Jul 2017
Breast cancer prediction and early detection: The potential value of cytomorphology and hTERT gene DNA methylation
Research article · 2013
Methylated Bone Morphogenetic Protein 3 (BMP3) Gene: Evaluation of Tumor Suppressor Function and Biomarker Potential in Biliary Cancer
Conference abstract · 30 Jan 2023
Cromolyn chitosan nanoparticles modulate the DNA methylation of RASSF1A and p16 tumor suppressor genes and lessen DNMT1 and METTL3 expression in MCF-7 breast cancer cell line
More from this journal
The newest in Journal of Molecular Biomarkers & Diagnosis.
Brief report · 29 Dec 2025
Biomarker Discovery To Clinical Translation: A Holistic Approach
Commentary · 29 Dec 2025
Molecular Diagnostics: Revolutionizing Precision Healthcare
Commentary · 29 Dec 2025
Genomic Biomarkers Revolutionizing Disease Diagnosis and Medicine
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Molecular Biomarkers & Diagnosis
- SubjectGenetics & Molecular Biology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Mina Dehbid”
- BylineArticles whose byline prints “Seyed Ahmad Aleyasin”
- BylineArticles whose byline prints “Hamidreza Vaziri”

